Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immunodeficiency”

1,042 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,042 results

Early research (Phase 1)Study completedNCT02157467
What this trial is testing

Study of Combined Oral Contraceptive Effects in Female Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 46
Large-scale testing (Phase 3)UnknownNCT00006397
What this trial is testing

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Who this might be right for
HIV Infections
PPD Development, LP 200
Testing effectiveness (Phase 2)Ended earlyNCT02355184
What this trial is testing

An Extension of Protocol PRO 140_CD01 Study

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Not applicableStudy completedNCT00004855
What this trial is testing

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Not applicableStudy completedNCT00015652
What this trial is testing

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)Study completedNCT00002447
What this trial is testing

Compare Two Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Hoffmann-La Roche 146
Not applicableStudy completedNCT00002168
What this trial is testing

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Large-scale testing (Phase 3)Study completedNCT00234923
What this trial is testing

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Who this might be right for
HIV Infection
Abbott 138
Testing effectiveness (Phase 2)Study completedNCT01002755
What this trial is testing

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaFatigueFever+7 more
M.D. Anderson Cancer Center 36
Not applicableUnknownNCT00216359
What this trial is testing

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

Who this might be right for
HIV InfectionsAntiretroviral Treatment
Institute for Interdisciplinary Infectiology 200
Post-approval studies (Phase 4)Study completedNCT01086878
What this trial is testing

Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

Who this might be right for
Acquired Immunodeficiency SyndromeInfant, NewbornAnemia+2 more
Harvard School of Public Health (HSPH) 222
Testing effectiveness (Phase 2)Study completedNCT00642291
What this trial is testing

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Who this might be right for
HIV Infections
Gilead Sciences 16
Large-scale testing (Phase 3)Study completedNCT00006154
What this trial is testing

Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 165
Testing effectiveness (Phase 2)WithdrawnNCT04370795
What this trial is testing

Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus

Who this might be right for
Severe Combined Immune Deficiency (SCID)
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00002177
What this trial is testing

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00931801
What this trial is testing

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Who this might be right for
HIV
Community Research Initiative of New England 43
Load More Results